tepotiniblung adenocarcinomapalliative radiotherapyMET-mutated non-small-cell lung cancer
… which achieved rapid relief. Following molecular confirmation, tepotinib—a selective MET tyrosine kinase inhibitor—was initiated. This r…
3articles mentioning drugs
3drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: tepotinib ×
tepotinib
This drug is selected. Its supporting articles are shown below.
Articles mentioning tepotinib
3 articles · page 1 of 1osimertinibcrizotinibsotorasibatezolizumabdurvalumablorlatinibosimertinib-treated
…ring may help identify patients who could benefit from extended osimertinib therapy, although further clinical validation is warranted.ctDN…
AdagrasibasibpembrolizumabsotorasibBI-2493G12CidocetaxeldaraxonrasibAZD4785RMC-7977
…d OS of 13.4 months,38 39 leading to full FDA approval in 2024. Adagrasib has also shown modest activity in PDAC (ORR 33%, PFS 5.4 months…